Navigation Links
Pharmacists' Workload Contributes To Errors

High workloads for pharmacists increase the potential for medication errors, says a new study by University of Arizona College of Pharmacy researchers// published in the May issue of the journal Medical Care.

The study was conducted by a team of researchers led by College of Pharmacy professor Daniel C. Malone, Ph.D., who is also a member of the Arizona Center for Education and Research on Therapeutics at the Critical Path Institute.

Researchers reviewed data submitted to insurance companies from 672 pharmacies in 18 metropolitan regions. The pharmacies filled an average of 18,000 prescriptions from January to March 2003, or 1,375 prescriptions per week. During that time, the average number of potentially harmful drug-drug interactions dispensed by each pharmacy was 32.1.

The pharmacies employed an average of 1.2 pharmacists for each hour the store was open, and each pharmacist filled an average of 14.1 prescriptions per hour. The risk of dispensing potentially harmful combinations of medications that could result in a drug interaction increased by 3 percent for each additional prescription filled per hour.

The study also found that computerized interaction alerts and telephone, Internet, and fax systems—which are intended to decrease pharmacist workload and increase the efficiency of prescription receipt and filling—also were associated with an increase in the number of prescriptions dispensed for medications that could interact.

“It appears that prescription volume is exceeding capacity and that automation and other pharmacy staffing may not sufficiently compensate for the increased pharmacist workload,” Malone says. “Additional research is needed to confirm and clarify this study, but our findings are consistent with other reports concerning workload and medication errors. We need to take a closer look at what we can do better in community pharmacies to reduce potentially dangerous interactions between d ispensed medicines.”

Source-Eurekalert
ED/B
'"/>




Related medicine news :

1. High Hospital House Staff Workload Associated With Worse Patient Outcomes
2. Railway Station Contributes to Create Awareness on AIDS
3. Parental Domestic Violence Contributes To Adolescent Depression
4. Increase in Waist Size Contributes To Increased Risk of Heart Disease
5. China Contributes Billions to Root Out Animal Diseases
6. Errors in medication
7. Reducing Medication Errors
8. Common Medication Errors in Children
9. More Errors From Computerized Prescriptions
10. Patients In Hospital ICUs At Risk From Medical Errors
11. 45 Percent Of Errors In Cancer Diagnosis Harm The Patient
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2016)... ... 06, 2016 , ... Experimentation involving human stem cells (HSCs) ... to its potential for revolutionizing human disease treatment. There are multiple HSC platforms ... cells (hiPSCs). , Both platforms have distinct advantages and disadvantages, but what ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... the much-anticipated HydroFX for Water®. This first-of-its-kind water-soluble powder supplement has a ... world’s most powerful antioxidants, molecular hydrogen, HydroFX for Water transforms every day ...
(Date:12/6/2016)... (PRWEB) , ... December 06, 2016 , ... TopConsumerReviews.com recently ... Mobility Scooters . , Mobility Scooters give freedom to people who need help ... Still others may be facing a long period of rehabilitation after an illness or ...
(Date:12/5/2016)... ... December 05, 2016 , ... "FCPX Overlay Glare is ... natural lighting effect without heavy rendering or complicated compositing," said Christina Austin - CEO ... to create an organic spectrum of lights that simulates the look of a glare. ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... and relationship-marketing firm, announced today that nominations will be accepted from December ... (ISE®) Central Awards. , Awards include the Information Security Executive® of the ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... CRANBURY, N.J. , Dec. 5, 2016 /PRNewswire/ ... pharmaceutical company, today presented data from two Phase ... poster sessions at the 58th annual meeting of ... San Diego, California . The two ... patients with acute myeloid leukemia (AML) and T-cell ...
(Date:12/5/2016)... Dec. 5, 2016   Lexicon Pharmaceuticals, Inc. ... from a Phase 2 clinical study of sotagliflozin, a ... collaboration with JDRF, the leading global organization funding type ... Phase 2 clinical trial, which randomized a total of ... once-daily 400 mg dose of sotagliflozin compared to a ...
(Date:12/5/2016)... 5, 2016  Sharn Anesthesia Inc. announced today that ... distribution partner for Salter Labs.  The company also received ... recognition of outstanding sales performance. Salter Labs ... anesthesia care, including the market gold standard ECO 2 ... distributor of the Parker Flex-Tip® Endotracheal Tube, which is ...
Breaking Medicine Technology: